Bring attention and solutions to patients living with rare diseases

Rare Disease Real World Proof PointsAdvances in rare disease treatments raise hope. Getting that hope to patients faces significant challenges.

IQVIA can help across the product lifecycle. Work with our clinical experts on innovative rare disease studies. Make sense of complicated data. Improve commercial decisions with our leading advanced analytics, machine learning and predictive analytics capabilities. With access to our deep clinical expertise, data and technology, you can identify the treating providers to help them find undiagnosed patients. Fast.

  • Optimize world-wide rare disease studies
  • Find undiagnosed patients and their treating HCPs
  • Raise targeted disease awareness and speed time to diagnosis

IQVIA has provided clinical services for more than 258 rare disease studies involving 22,570 patients in 87 countries world-wide since 2011.

Let us help you optimize your rare disease treatment.

Orphan Designations
350 million people worldwide are living with a rare disease. More than the entire population of the United States. But only 5% of those known rare diseases have an approved treatment. Coté Orphan, an IQVIA company, wants to change that.
Predictive and Prescriptive Analytics
Human Data Science uses data science, healthcare expertise and human data together to better measure and improve health decisions and outcome. And IQVIA is positioned to help you tap its potential.
Learn more about Human Data Science in our latest issue of AccessPoint, The Rise of Human Data Science in the Real World